Pure Global AI
NCT06389981Not yet recruiting

Co-Design and Pilot Testing of Peer-led Community Outreach to Improve Equity, Veteran-Centeredness and Uptake of Lung Cancer Screening

VA Boston Healthcare SystemClinicalTrials.govother
Study focus
Disease/Condition
Lung Cancer
Drug/Device/Intervention
Veterans peer connect Program
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
VA Boston Healthcare System
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2024
End date
Jun 30, 2025
Enrollment
40 participants
Primary outcome

Lung Cancer Screening Uptake

Summary

Co-design will be implemented to develop an innovative, Veteran-centered intervention (Vet
 Peer Connects program) that meets the needs of Black Veterans.
 
 Next, a feasibility pilot test of the Vet Peer Connects program will be conducted. The Peer
 will lead up to 4 group lung cancer screening orientations in community partner sites to
 reach around 40 lung cancer screening eligible Black Veterans. The Peer will provide
 one-to-one tailored support to up to 15 Veterans (coaching, goal-setting, navigation to
 access Veterans Affairs lung cancer screening). Then, the study team will evaluate program
 delivery through ethnographic observation and field notes, Peer activity logs, and weekly
 check-ins between the study team and Peer. Investigators will interview Veteran participants,
 community partners, and lung cancer screening clinical staff to explore feasibility and
 acceptability of the Vet Peer Connects program and solicit suggestions for improvement.
 Preliminary data on the outcomes of the Vet Peer Connects program will be collected by study
 team through administering surveys to assess change in Social Cognitive Theory constructs,
 and extracting lung cancer screening uptake and tobacco treatment 3 months post enrollment
 from VA's Corporate Data Warehouse. This work will inform a subsequent multi-site
 stepped-wedge trial to assess effectiveness, implementation, and cost of the Vet Peer
 Connects program in VA lung cancer screening sites and neighboring branches of the National
 Association for Black Veterans

ICD-10 classifications
Carcinoma in situ: Bronchus and lungSecondary malignant neoplasm of lungMalignant neoplasm of bronchus and lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm: Overlapping lesion of bronchus and lung
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06389981
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06389981 through Pure Global AI's free database. This phase not specified trial is sponsored by VA Boston Healthcare System and is currently Not yet recruiting. The study focuses on Lung Cancer. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.